sulfonylureas (SUs)

Hypoglycemia and diabetes: a report of a workgroup of the american diabetes association and the endocrine society.

Seaquist, Elizabeth R; Anderson, John; Childs, Belinda; Cryer, Philip; Dagogo-Jack, Samuel; Fish, Lisa; Heller, Simon R; Rodriguez, Henry; Rosenzweig, James; Vigersky, Robert

Diabetes care; 2013 May;36(5):1384-95. PMID: 23589542;

Category: General Reviews;

Tags: beta cell pathophysiology, glycemic control, insulin therapy, sulfonylureas (SUs), weight

Year in Diabetes 2012: The Diabetes Tsunami

R. Sherwin and A. M. Jastreboff

Journal of Clinical Endocrinology and Metabolism

Category: General Reviews;

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight

Podcast: A Discussion About 2012 ADA/EASD Position Statement

Posted August 2, 2012 by Doron Schneider, MD, FACP

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight

Listen to the Podcast and/or read the transcript.

Add new comment

A Discussion About the 2012 ADA/EASD Position Statement

Tags: GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight

Dr. Doron Schneider and Dr. Jack Leahy discuss the 2012 ADA/EASD position statement on management of type 2 diabetes and its implications to clinical care.

The Good, The Bad, and the Ugly Part II: Why I’m not a Fan of the ADA/EASD’s 2012 Position Statement

Posted June 6, 2012 by John L. Leahy, MD

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight

In my last blog, I explained why I’m not a fan of the highly awaited ADA/EASD position statement on management of type 2 diabetes,

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Inzucchi, Silvio E; Bergenstal, Richard M; Buse, John B; Diamant, Michaela; Ferrannini, Ele; Nauck, Michael; Peters, Anne L; Tsapas, Apostolos; Wender, Richard; Matthews, David R

Diabetes care; 2012 Jun;35(6):1364-79. PMID: 22517736;

Category: Additional Resources / Guidelines;

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

Rodbard, Helena W; Jellinger, Paul S; Davidson, Jaime A; Einhorn, Daniel; Garber, Alan J; Grunberger, George; Handelsman, Yehuda; Horton, Edward S; Lebovitz, Harold; Levy, Philip; Moghissi, Etie S; Schwartz, Stanley S

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; 15(6):540-59. PMID: 19858063 ;

Category: General Reviews;

Tags: DPP-4 inhibitors, GLP-1 agonists, glycemic control, insulin therapy, lifestyle changes, metformin, prediabetes, sulfonylureas (SUs), thiazolidinediones (TZDs), weight

Betacell

A resource for physicians established by the Endocrine Society

Text Size:

About Topics

Hypoglycemia and diabetes: a report of a workgroup of the american diabetes association and the endocrine society.

Year in Diabetes 2012: The Diabetes Tsunami

Challenges of Accelerating Treatment to Get to Goal

Combination Therapies and Intensification of Therapy

Treatment failure, Non-responders, and Non-adherence

Podcast: A Discussion About 2012 ADA/EASD Position Statement

A Discussion About the 2012 ADA/EASD Position Statement

The Good, The Bad, and the Ugly Part II: Why I’m not a Fan of the ADA/EASD’s 2012 Position Statement

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.